Renascience

Renascience DSCR

The Debt Service Coverage Ratio (DSCR) of Renascience (4889.T) as of Nov 19, 2026 is -0.65. In the previous year, Debt Service Coverage Ratio (DSCR) was -0.92 — a change of -29.59% (higher).

DSCR

-0.65

YoY

-29.59%

Last updated:

Debt Service Coverage Ratio (DSCR) of Renascience is 2024 -0.65 . Debt Service Coverage Ratio (DSCR) of Renascience was 2023 -0.92 . It decreases by -29.59% higher compared to the previous year.

The Renascience DSCR history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

DSCR
Date
DSCR
Jan 1, 2020
-0.47 JPY
Jan 1, 2021
-0.19 JPY
Jan 1, 2022
-1.16 JPY
Jan 1, 2023
-0.92 JPY
Jan 1, 2024
-0.65 JPY
The Renascience DSCR history
YEARDSCRYoY
-0.65-29.59%
-0.92-20.53%
-1.16+516.54%
-0.19-60.01%
-0.47—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Renascience Stock analysis

What does Renascience do? Renascience, Inc. develops and sells pharmaceuticals, focusing on drugs for four non-infectious aging-related diseases: cancer, diabetes, respiratory diseases, and cardiovascular diseases. The company collaborates with physicians in research and development of pharmaceuticals, medical devices, and AI solutions for medical problems. Its products target aging-related health issues, including women's and children's diseases and solutions for COVID-19 infection. The firm's revenue comes from the sale of developed pharmaceuticals, medical devices, and AI solutions. Physicians and medical institutions are key buyers of its products, as the company's R&D is conducted in collaboration with them. The primary market segments are aging populations suffering from chronic conditions and healthcare providers seeking innovative medical solutions. Renascience, Inc. operates with a small team of three full-time employees, emphasizing focused R&D on specific medical challenges. Its business model centers on developing targeted therapies for high-impact diseases, leveraging partnerships with physicians to address unmet medical needs in aging-related health conditions. Renascience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Renascience stock

Debt Service Coverage Ratio (DSCR) of Renascience is -0.65 in 2024.

Debt Service Coverage Ratio (DSCR) of Renascience changed from -0.92 to -0.65, representing a -29.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) Renascience since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s Renascience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Renascience

All Key Metrics — Renascience